Please login to the form below

heart attack

This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.

Novartis withdraws EU filing for canakinumab

The company has completed a phase 3 study of canakinumab as a treatment to prevent stroke and myocardial infarction (MI) or death in patients who have already suffered a heart attack - ... This showed that injections of canakinumab every three months

Latest news

MS and cholesterol drugs picked for new UK rapid uptake push

High sensitivity troponin tests for early rule out of myocardial infarction (acute) - Diagnostic tests that detect whether or not a patient is at risk or previously had a heart attack. ... innovation.”. Another company pleased with the selected
CGRP migraine drugs need prior approval for use, recommends ICER

and potential harms” of these new drugs, noting that the FDA has requested additional research into liver toxicity and risks for heart attack and stroke after exposure to erenumab, and into
NHS could save £7bn with greater diagnostics use

The report specifically evaluated the savings of three existing IVD tests - covering suspected heart attacks, pre-eclampsia in pregnancy and diagnosing irritable bowel syndrome (IBS) - if widely used. ... It found that using the high sensitivity cardiac
Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Amgen’s FOURIER reduced heart attack risks by 27%, stroke risks by 21% and coronary revascularisations by 22%, but didn't provide a mortality benefit. ... Herceptin, which could reduce their risk of heart damage while making significant cost-savings
Amgen gets prevention claim for cholesterol drug Repatha

The new label is based on the results of the FOURIER trial, which showed that the drug reduced the risk of heart attack by 27%, the risk of stroke by 21% ... In the US, every 40 seconds someone has a heart attack or stroke, and nearly one in three of

More from news
Approximately 5 fully matching, plus 203 partially matching documents found.

Latest Intelligence

Insights from Cannes Lions Health Festival 2018

sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
Proving real-world value

Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
Why health psychology is the answer to tackling adherence

Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
Transforming times at AstraZeneca

She gives the example of a drug to prevent a second heart attack that has a positive NICE recommendation, can save people's lives and reduce further hospital costs. ... After a heart attack people tend to leave the hospital thinking the event is over.
The rise of chronic disease in BRIC markets

Cardiovascular diseases – such as heart attack, stroke, DVT and atrial fibrillation – also present a major problem in Russia, with 46 per cent of self-reported sufferers (39 per cent being diagnosed). ... Analysts predict that ischaemic heart disease

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018

heart attack to a shark attack out at sea. ... The impactful film is designed to urge cardiologists to keep treating heart attack victims to reduce the risk of often fatal second heart attacks.
Health knowledge: Why is it so important?

Smokers know the dangers but smoke anyway, and inactive people know moving more would result in better overall health and less chance of developing a heart condition, but continue to prefer ... We are also more likely to change behaviour in response to
Understanding the "Big Picture"

In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Senior Account Director development role to Business Director, H...: Excellent package

Account Director, Healthcare Marketing Agency: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Director – Healthcare PR – Global Agency: Salary TBC

Senior Medical Writer: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director, Medical Education: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Manager / Account Director: Competative

Account Director – Healthcare Marketing – Berks: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Associate Director: £75, 000-90, 000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director: Competitive Salary Offered

Global Business Development Director – Health Education: excellent commission

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Business Director: Competitive Salary Offered

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch: ...